Publications in top medical journals: Nature Medicine, Nature Communications, Translational Psychiatry, eClinicalMedicine, Communications Medicine, Journal of General Internal Medicine, Scientific Reports, Cell Patterns, Archives of Pathology & Laboratory Medicine, etc.
Publications in leading computer science venues: KDD, AAAI, TKDE, ICDM, etc.
ICDM'18 Best Paper Candidate; Best Paper Award at AAAI'20 Workshop on Deep Learning on Graphs
Research, algorithms, and code adopted by NVIDIA, Boehringer Ingelheim, etc.
Work featured in media outlets including Fortune, Nature Medicine, NIH News, NIH Director’s Blog, BMJ News, etc.
Co-Investigator on NIH grants: Autism Data Science Initiative (2025–2028), RECOVER Initiative (2021–2025), R01AG080991 (2023–2027)
NIH Early Career Reviewer (2024)
AMIA Informatics Year-In-Review selection (2024)
Research Experience
Assistant Professor, Department of Population Health Sciences, Weill Cornell Medicine (May 2025 – present)
Instructor, Department of Population Health Sciences, Weill Cornell Medicine (May 2022 – Apr 2025)
Researcher at Weill Cornell Medicine, Cornell University, collaborating with Prof. Fei Wang (Feb 2019 – Apr 2022)
Postdoctoral Fellow, Biostatistics & Data Science Americas, Boehringer Ingelheim Pharmaceuticals, Inc. (Mar 2020 – Jan 2021)
Tencent WeChat Rhino-Bird Elite Training Program (Jul 2018 – Oct 2018)
Visiting Scholar, Center for Complex Network Research, working with Prof. Albert-László Barabási (Jun 2017 – May 2018)
Summer research with Prof. Christos Faloutsos (Carnegie Mellon University) in 2015 & 2016
Summer research with Prof. Chaoming Song (Miami University) in 2014 & 2015
Background
Currently Assistant Professor of Population Health Sciences, Division of Health Informatics and Artificial Intelligence, Weill Cornell Medicine, Weill Medical College of Cornell University
Faculty member at the WCM Institute of AI for Digital Health (AIDH)
Long-term research focus on AI for Health (AI4Health)
Currently leverages AI, machine learning, and large-scale Real-World Data (RWD) to generate robust, generalizable, high-throughput Real-World Evidence (RWE)
Aims to address major health challenges including Alzheimer's Disease, Long COVID, youth suicide, women's health, and accelerate drug discovery and development